Table 1.
Correlation between hepcidin expression and clinicopathological characteristics in TMA of ccRCC (n=80)
| Characteristics | Case | Hepcidin expression | X 2 | P value | |
|---|---|---|---|---|---|
|
| |||||
| Low | High | ||||
| All cases | 80 | 37 | 43 | ||
| Age (years) | 3.948 | 0.047* | |||
| <60 | 38 | 22 | 16 | ||
| ≥60 | 42 | 15 | 27 | ||
| Gender | 0.002 | 0.961 | |||
| Male | 56 | 26 | 30 | ||
| Female | 24 | 11 | 13 | ||
| Laterality | 0.453 | 0.501 | |||
| Left | 40 | 20 | 20 | ||
| Right | 40 | 17 | 23 | ||
| T stage | 6.772 | 0.009** | |||
| T1 & T2 | 53 | 30 | 23 | ||
| T3 & T4 | 27 | 7 | 20 | ||
| N stage | 1.478 | 0.224 | |||
| N0 | 75 | 36 | 39 | ||
| N1 | 5 | 1 | 4 | ||
| M stage | 0.765 | 0.382 | |||
| M0 | 76 | 36 | 40 | ||
| M1 | 4 | 1 | 3 | ||
| Pathologic stage | 6.374 | 0.012* | |||
| I & II | 51 | 29 | 22 | ||
| III & IV | 29 | 8 | 21 | ||
| WHO grade | 0.135 | 0.713 | |||
| G1 & G2 | 45 | 20 | 25 | ||
| G3 & G4 | 35 | 17 | 18 | ||
P<0.05;
P<0.01.